Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2012
07/12/2012US20120178763 Method of Treating Anxious Major Depressive Disorder
07/12/2012US20120178761 Pyrrolidine derivatives
07/12/2012US20120178760 Heterocyclic-Fused Pyrazolo[4,3-c] Pyridin-3-One M1 Receptor Positive Allosteric Modulators
07/12/2012US20120178752 Rho kinase inhibitors
07/12/2012US20120178748 Heteroaryl compounds and methods of use thereof
07/12/2012US20120178747 Compositions and methods for bone formation and remodeling
07/12/2012US20120178745 Novel Crystalline Oxazine Derivative
07/12/2012US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase
07/12/2012US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/12/2012US20120178738 Dibenzo [b,f] [1,4]oxazapine compounds
07/12/2012US20120178736 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
07/12/2012US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
07/12/2012US20120178724 Compositions for Reducing the Incidence of Drug Induced Arrhythmia
07/12/2012US20120178719 Modulation of phospholipase d for the treatment of neurodegenerative disorders
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178713 Phenyl sulphonamides as modulators of ion channels
07/12/2012US20120178708 Phenethylsulfone isoindoline derivatives and their use
07/12/2012US20120178696 Compositions and Methods for Modulating AMPA Receptor-mediated Excitotoxicity
07/12/2012US20120178695 Methods of treating neuropathic pain
07/12/2012US20120178682 GB1 Peptidic Compounds and Methods for Making and Using the Same
07/12/2012US20120178681 Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment
07/12/2012US20120178676 Pegylated c-peptide
07/12/2012US20120178675 Compositions And Methods For Modulating The Pharmacokinetics and Pharmacodynamics of Insulin
07/12/2012US20120178669 Protease inhibitors, compositions and methods of use
07/12/2012US20120178666 Prodrugs of guanfacine
07/12/2012US20120178629 Apparatus and methods for preparing an emulsion
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177754 Inhibitor of inflammatory conditions
07/12/2012US20120177738 Green tea extracts of improved bioavailability
07/12/2012US20120177735 Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
07/12/2012US20120177733 Solid dosage forms of valsartan and amlodipine and method of making the same
07/12/2012US20120177732 Concentration and mental performance amplifying formulation
07/12/2012US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics
07/12/2012US20120177706 Stable combinations of amlodipine besylate and benazepril hydrochloride
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177670 Somatic Stem Cells
07/12/2012US20120177664 Antibodies That Specifically Bind to A Beta Oligomers and Use Thereof
07/12/2012US20120177655 Anti-human il-21 monoclonal antibodies
07/12/2012US20120177654 Method of treatment and agents useful for same
07/12/2012US20120177639 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
07/12/2012US20120177630 Treatment of rett syndrome and other disorders
07/12/2012US20120177626 Hdl comprising a therapeutic agent and use in therapy
07/12/2012US20120177614 Culture method to obtain and maintain a pure or enriched population of mammalian neural stem cells and/or neural/progenitor cells that are prone to differentiate into oligodendrocyte-lineage cells in vitro
07/12/2012US20120177612 Methods for treating and/or reversing neurodegenerative diseases and/or disorders
07/12/2012US20120177605 Delivery of Polynucleotides Across the Blood-Brain-Barrier Using Recombinant AAV9
07/12/2012US20120177600 Compositions and Methods for Inducing or Enhancing Connective Tissue Repair
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/12/2012US20120177594 Polyion complex comprising phd2 expression inhibiting substance
07/12/2012US20120177575 Fas (apo-1,cd95) targeted platforms for intracellular drug delivery
07/12/2012US20120177572 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
07/12/2012DE102011008153A1 Preparing monoclonal antibody comprises immunizing mice with alpha synuclein peptide, removing and fusing B-lymphocytes with myeloma cell line, selecting fusion product peptide in cell culture vessel, selecting immunoglobulin and isolating
07/12/2012DE102011008070A1 Use of tocotrienol for prevention, aftercare, treatment or auxiliary treatment of proliferative diseases, inflammatory diseases, heart disease, diseases of nervous system, and aftercare of surgical interventions or mitigation of swelling
07/12/2012CA2823935A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
07/12/2012CA2822907A1 Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy
07/12/2012CA2822777A1 Fused aminodihydrothiazine derivatives
07/12/2012CA2822775A1 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease
07/12/2012CA2821640A1 Pyrrolidine derivatives as nk3 antagonists
07/11/2012EP2474544A1 Therapeutic agent for anxiety disorders
07/11/2012EP2474543A1 Therapeutic agent for mood disorders
07/11/2012EP2474522A1 Agomelatine and pharmaceutical compositions thereof
07/11/2012EP2474315A1 Immunity inducer
07/11/2012EP2474309A1 Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same
07/11/2012EP2473513A1 Compounds as tyrosine kinase modulators
07/11/2012EP2473490A1 (thio)morpholine derivatives as s1p modulators
07/11/2012EP2473488A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy
07/11/2012EP2473479A1 Therapeutic aryl-am i do-aryl compounds and their use
07/11/2012EP2473478A2 Novel uses
07/11/2012EP2473199A1 Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders
07/11/2012EP2473185A1 Treatment of neurological or neurodegenerative disorders
07/11/2012EP2473179A1 Nigella extracts for the treatment of symptoms connected to impaired or imbalanced neurotransmission
07/11/2012EP2473176A1 Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease
07/11/2012EP2473174A2 Ganglioside transmucosal formulations
07/11/2012EP2473171A2 Methods of treating mitochondrial disorders using metalloporhyrins
07/11/2012EP2473166A2 Treatment and prevention of secondary injury after trauma or damage to the central nervous system
07/11/2012EP2473069A2 Tea based smoking product
07/11/2012EP2473055A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
07/11/2012EP2473048A1 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
07/11/2012EP2473039A1 Durable treatment with 4-aminopyridine in patients with demyelination
07/11/2012EP2473038A1 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
07/11/2012EP2010535B1 Thioxanthine derivatives and their use as inhibitors of mpo
07/11/2012EP1979316B1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
07/11/2012EP1915156B1 Use of psychomotor stimulants and compositions containing them in a method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion
07/11/2012EP1628652B1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression
07/11/2012EP1487778B1 Substituted 4-aminocyclohexanols
07/11/2012EP1472224B1 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
07/11/2012EP1470121B1 Pyrimidine derivatives as rho-kinase inhibitors
07/11/2012EP1300416B1 Memory-enhancing peptides and the use thereof
07/11/2012CN202314491U 小儿镇静镇痛含服剂型 Pediatric sedation sublingual formulation
07/11/2012CN1900074B Substituted oxazolidinones and their use in the field of blood coagulation
07/11/2012CN1805937B N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine D3 receptor.
07/11/2012CN1688532B Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
07/11/2012CN102574915A Antibodies that specifically bind to A beta oligomers and use thereof
07/11/2012CN102574890A Certain chemical entities, compositions, and methods
07/11/2012CN102574869A 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
07/11/2012CN102574864A Fused aminodihydropyrimidone derivatives
07/11/2012CN102574857A Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/11/2012CN102574844A Maleic acid salt and crystal thereof
07/11/2012CN102574832A Substituted N-phenyl-1-(4-pyridinyl)-1H-pyrazol-3-amines
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 1833